Literature DB >> 19703020

Peripheral immune response in pulmonary tuberculosis.

E Aktas1, F Ciftci, S Bilgic, O Sezer, E Bozkanat, O Deniz, U Citici, G Deniz.   

Abstract

Cellular immune response and delayed-type hypersensitivity reactions are considered to play a major role in the immunopathogenesis of pulmonary tuberculosis (PTB). But the exact mechanism is still to be clarified. Th1 cells are mainly involved in cellular immune responses in PTB and provide a normal healing process with minimal or no sequela whereas Th2 cell and CD8(+) T lymphocyte responses may lead to more severe type of disease. In this study, we investigated the peripheral blood immune responses in PTB. The study group consisted of acid fast positive young male soldiers with PTB and a negative HIV serology. The control group included healthy young volunteer male soldiers without a history of PTB. Intracytoplasmic cytokine content of CD8(+) T cells and lymphocytes, including IL-2, IL-4, IL-5, IL-10 and IFN-gamma were determined by flow cytometry, and IL-2, IL-4, IL-5, IL-10, IFN-gamma and TNF-alpha serum levels were measured by cytometric bead array (CBA). No difference was observed between the percentages of T, B, NK cells and HLA-DR expression in both groups, however, the number of CD3(+)HLA-DR(+) activated T cell percentages was higher in PTB group as compared to healthy subjects. IL-2, IL-4, IL-5, IL-10 contents of lymphocytes and IFN-gamma(+)CD8(+) T cells were found to be significantly lower in PTB patients when compared with healthy subjects, and in parallel, serum IL-2, IL-4, IL-5 and TNF-alpha levels were also significantly lower in PTB patients. In conclusion we suggest that, CD8(+) T cells producing both Th1 and Th2 type cytokines, may play important role in the peripheral immune response to mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19703020     DOI: 10.1111/j.1365-3083.2009.02294.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

1.  Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.

Authors:  Shihoko Komine-Aizawa; Toshio Yamazaki; Tsuyoshi Yamazaki; Shin-Ichiro Hattori; Yuji Miyamoto; Naoki Yamamoto; Shinji Haga; Masahiko Sugitani; Mitsuo Honda; Satoshi Hayakawa; Saburo Yamamoto
Journal:  Clin Vaccine Immunol       Date:  2010-08-04

2.  Modulation of iron status biomarkers in tuberculosis-diabetes co-morbidity.

Authors:  Nathella Pavan Kumar; Vaithilingam V Banurekha; Dina Nair; Chandrakumar Dolla; Paul Kumaran; Subash Babu
Journal:  Tuberculosis (Edinb)       Date:  2017-11-24       Impact factor: 3.131

3.  Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection.

Authors:  Francesca Conradie; Andrea S Foulkes; Prudence Ive; Xiangfan Yin; Katerina Roussos; Deborah K Glencross; Denise Lawrie; Wendy Stevens; Luis J Montaner; Ian Sanne; Livio Azzoni
Journal:  J Acquir Immune Defic Syndr       Date:  2011-11-01       Impact factor: 3.731

4.  Association of CTLA4 gene polymorphisms with susceptibility and pathology correlation to pulmonary tuberculosis in Southern Han Chinese.

Authors:  Chong Wang; Tingting Jiang; Liliang Wei; Fujian Li; Xiaojun Sun; Dapeng Fan; Jiyan Liu; Xing Zhang; Dandan Xu; Zhongliang Chen; Zhongjie Li; Xiaoyan Fu; Ji-Cheng Li
Journal:  Int J Biol Sci       Date:  2012-07-10       Impact factor: 6.580

5.  Sarcoidosis and tuberculosis cytokine profiles: indistinguishable in bronchoalveolar lavage but different in blood.

Authors:  Muhunthan Thillai; Christian Eberhardt; Alex M Lewin; Lee Potiphar; Suzie Hingley-Wilson; Saranya Sridhar; Jonathan Macintyre; Onn Min Kon; Melissa Wickremasinghe; Athol Wells; Mark E Weeks; Donald Mitchell; Ajit Lalvani
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

6.  Diminished plasma levels of common γ-chain cytokines in pulmonary tuberculosis and reversal following treatment.

Authors:  Nathella Pavan Kumar; Vaithilingam V Banurekha; Dina Nair; Subash Babu
Journal:  PLoS One       Date:  2017-04-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.